Article
Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor
3 May 2024
Abstract excerpt
Estrogen receptor (ER) β (ERβ) is the second ER subtype that mediates the effects of estrogen in target tissues along with ERα that represents a validated biomarker and target for endocrine therapy in breast cancer. ERα was the only known ER subtype until 1996 when the discovery of ERβ opened a new chapter in endocrinology and prompted a thorough reevaluation of the estrogen signaling paradigm. Unlike the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
